18. Spinocerebellar degeneration Clinical trials / Disease details

Clinical trials : 76 / Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03933163 (ClinicalTrials.gov)	May 23, 2019	16/4/2019	Micronised Resveratrol as a Treatment for Friedreich Ataxia	A Randomised Placebo-controlled Crossover Trial of Micronised Resveratrol as a Treatment for Friedreich Ataxia	Friedreich Ataxia	Drug: Resveratrol	Murdoch Childrens Research Institute	NULL	Active, not recruiting	16 Years	N/A	All	40	Phase 2	Australia
2	NCT01339884 (ClinicalTrials.gov)	April 2011	14/4/2011	A Study of Resveratrol as Treatment for Friedreich Ataxia	An Open Label Clinical Pilot Study of Resveratrol as Treatment for Friedreich Ataxia	Friedreich Ataxia	Drug: Resveratrol	Murdoch Childrens Research Institute	Friedreich's Ataxia Research Alliance	Completed	18 Years	N/A	Both	27	Phase 1/Phase 2	Australia